ALBIREO PHARMA INC's ticker is ALBO and the CUSIP is 01345P106. A total of 97 filers reported holding ALBIREO PHARMA INC in Q4 2021. The put-call ratio across all filers is 0.54 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,031,000 | +327.8% | 53,300 | +338.9% | 0.05% | +380.0% |
| Q2 2022 | $241,000 | -57.6% | 12,143 | -36.4% | 0.01% | -50.0% |
| Q1 2022 | $568,000 | +43.1% | 19,082 | +11.7% | 0.02% | +42.9% |
| Q4 2021 | $397,000 | -25.5% | 17,082 | 0.0% | 0.01% | -39.1% |
| Q3 2021 | $533,000 | +2.5% | 17,082 | +15.6% | 0.02% | +9.5% |
| Q2 2021 | $520,000 | -11.0% | 14,774 | -10.9% | 0.02% | -12.5% |
| Q1 2021 | $584,000 | +81.4% | 16,574 | +93.3% | 0.02% | +100.0% |
| Q4 2020 | $322,000 | -91.8% | 8,574 | -92.7% | 0.01% | -93.5% |
| Q3 2020 | $3,930,000 | – | 117,800 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 1,704,330 | $60,504,000 | 1.59% |
| Birchview Capital, LP | 38,000 | $1,349,000 | 0.92% |
| Virtus ETF Advisers LLC | 24,688 | $876,000 | 0.77% |
| BVF INC/IL | 220,000 | $7,810,000 | 0.76% |
| SECTORAL ASSET MANAGEMENT INC | 172,803 | $6,135,000 | 0.69% |
| Chicago Capital, LLC | 134,748 | $4,784,000 | 0.39% |
| Artal Group S.A. | 500,000 | $17,750,000 | 0.38% |
| TPG Group Holdings (SBS) Advisors, Inc. | 716,381 | $25,432,000 | 0.33% |
| Eversept Partners, LP | 18,029 | $640,030 | 0.29% |
| HEARTLAND ADVISORS INC | 125,000 | $4,438,000 | 0.29% |